Eduardo Vilar-Gomez (Eduardo Vilar Gomez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Topics

Physical Activity

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Hepatology communications

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Niharika Samala, Eduardo Vilar-Gomez
Editorial: Enriching our understanding of MASLD through representation of under-reported populations. Alimentary pharmacology & therapeutics 59 (12) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living with HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Niharika Samala, Eduardo Vilar-Gomez
Editorial: Enriching our understanding of MASLD through representation of under-reported populations. Alimentary pharmacology & therapeutics 59 (12) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living with HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Naga P Chalasani, Eduardo Vilar-Gomez, Stephen Caldwell, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah A Terrault, Laura A Wilson, James Tonascia, Arun J Sanyal
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Niharika Samala, Eduardo Vilar-Gomez
Editorial: Enriching our understanding of MASLD through representation of under-reported populations. Alimentary pharmacology & therapeutics 59 (12) (2024)
Niharika Samala, Eduardo Vilar-Gomez
Editorial: Enriching our understanding of MASLD through representation of under-reported populations. Alimentary pharmacology & therapeutics (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Maria Gaurnizo-Ortiz, Lauren D Nephew, Eduardo Vilar-Gomez, Carla D Kettler, James E Slaven, Marwan S Ghabril, Archita P Desai, Eric S Orman, Naga Chalasani, Samer Gawrieh, Kavish R Patidar
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Kavish R Patidar, Maria Guarnizo Ortiz, James E Slaven Ii, Lauren D Nephew, Eduardo Vilar-Gomez, Carla D Kettler, Marwan S Ghabril, Archita P Desai, Eric S Orman, Naga Chalasani, Samer Gawrieh
Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis. Hepatology communications 7 (12) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Maria Guarnizo-Ortiz, Eduardo Vilar-Gomez
Editorial: first-degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis. Alimentary pharmacology & therapeutics 57 (9) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Eduardo Vilar-Gomez
Editorial: food insecurity, diet quality, racial and ethnic disparities in non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
Terry Cheuk Fung Yip, Eduardo Vilar-Gomez, Salvatore Petta, Yusuf Yilmaz, Grace Lai-Hung Wong, Leon A Adams, Victor de Lédinghen, Silvia Sookoian, Vincent Wai-Sun Wong
Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology (Baltimore, Md.) (2022)
Eduardo Vilar-Gomez, Carlos Jose Pirola, Silvia Sookoian, Laura A Wilson, Tiebing Liang, Naga P Chalasani
PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features. Hepatology (Baltimore, Md.) 76 (5) (2022)
Samer Gawrieh, Laura A Wilson, Katherine P Yates, Oscar W Cummings, Eduardo Vilar-Gomez, Veeral H Ajmera, Kris V Kowdley, William M Rosenberg, James Tonascia, Naga P Chalasani
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. Hepatology communications 5 (5) (2021)
Luis Calzadilla Bertot, Eduardo Vilar-Gomez, Jacob George, Leon A Adams
REPLY. Hepatology (Baltimore, Md.) 74 (1) (2021)
Eduardo Vilar-Gomez, Lauren D Nephew, Raj K Vuppalanchi, Samer Gawrieh, Andrea Mladenovic, Francis Pike, Niharika Samala, Naga P Chalasani
High quality diet, physical activity and college education are associated with low risk of NAFLD among the U.S. population. Hepatology (Baltimore, Md.) (2021)
Luis Calzadilla Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Manuel Romero, Rocio Aller-de la Fuente, Grace Lai-Hung Wong, Marlen Ivón Castellanos-Fernández, Mohammed Eslam, Archita P Desai, Gary P Jeffrey, Jacob George, Naga P Chalasani, Leon A Adams
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis. Hepatology (Baltimore, Md.) 73 (6) (2021)
Eduardo Vilar-Gomez, Naga Chalasani
Reply. Hepatology (Baltimore, Md.) 70 (2) (2020)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Eduardo Vilar-Gomez, Raj Vuppalanchi, Samer Gawrieh, Marwan Ghabril, Romil Saxena, Oscar W Cummings, Naga Chalasani
Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. Hepatology (Baltimore, Md.) 71 (2) (2019)
Eduardo Vilar-Gomez, Raj Vuppalanchi, Archita P Desai, Samer Gawrieh, Marwan S Ghabril, Romil Saxena, Oscar W Cummings, Naga Chalasani
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Alimentary pharmacology & therapeutics 50 (3) (2019)
Lara Dakhoul, Samer Gawrieh, Keaton R Jones, Marwan Ghabril, Chelsey McShane, Eric Orman, Eduardo Vilar-Gomez, Naga Chalasani, Lauren Nephew
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden. Hepatology communications 3 (1) (2018)
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Scott L Friedman, Bienvenido Gra-Oramas, Licet Gonzalez-Fabian, Sacha Lazo-Del Vallin, Moises Diago, Leon A Adams
Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH. Liver international : official journal of the International Association for the Study of the Liver 37 (12) (2017)